Gold futures down for the session, gain for the week
Gold futures fell Friday , easing back from a gain a day earlier, but posted a climb of about 2.2% for the week. Prices saw "a normal trading pullback after encountering technical resistance near $1,740," said Colin Cieszynski, chief market strategist at SIA Wealth Management. "Volumes have dropped off as well, suggesting this is just normal backing and filling with bulls taking a day off after two days [of gains] or running up on higher volumes, he told MarketWatch. June gold gcm20 fell $9.80, or 0.6%, to settle at $1,735.60 an ounce.
Shares of Inovio Pharmaceuticals Inc.  declined 15.3% in trading on Wednesday after Maxim Group downgraded the stock to hold from buy. Inovio, which is developing a COVID-19 vaccine, had announced some limited, clinical data about how the candidate performed in a Phase 1 trial on Tuesday. Maxim analysts said it appears that the COVID-19 "opportunity" is already baked into the valuation as shares of Inovio have soared 593.0% year-to-date. "In our opinion, the success of INO-4800 is priced into the shares," they wrote in a note to investors on Wednesday. The company's stock hit a record high of $31.69 on Monday, the day before it released the positive, yet limited data about its vaccine candidate. Inovio said that the full trial data will be published in a peer-reviewed medical journal. The stock then tumbled after it shared the data on Tuesday, closing at $26.95. The S&P 500  is down 4.0% year-to-date.
